Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments

Amastigotes from L. (L.)amazonensis (La), L. (L.)venezuelensis (Lv), L. (V.)brasiliensis (Lb), and L. (L.)chagasi (Lch) were cultured in a free cells liquid culture medium. Patients (n=87) from a cutaneous leishmaniasis (CL) hyperendemic region receiving different treatments were followed up from Ja...

Full description

Saved in:
Bibliographic Details
Main Authors: José A. O'Daly, Humberto M. Spinetti, Joe Gleason, María B. Rodríguez
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Parasitology Research
Online Access:http://dx.doi.org/10.1155/2013/657016
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549292438454272
author José A. O'Daly
Humberto M. Spinetti
Joe Gleason
María B. Rodríguez
author_facet José A. O'Daly
Humberto M. Spinetti
Joe Gleason
María B. Rodríguez
author_sort José A. O'Daly
collection DOAJ
description Amastigotes from L. (L.)amazonensis (La), L. (L.)venezuelensis (Lv), L. (V.)brasiliensis (Lb), and L. (L.)chagasi (Lch) were cultured in a free cells liquid culture medium. Patients (n=87) from a cutaneous leishmaniasis (CL) hyperendemic region receiving different treatments were followed up from January 1994 to August 2000. Time for remission of lesions were spontaneous remission (SR) 7 weeks; Glucantime (Glu) chemotherapy 9 weeks; immunotherapy with La, Lv, Lb, and Lch amastigotes Tosyl-Lysil Chloromethyl-ketone (TLCK) treated and Nonidet P-40(NP-40) extracted (VT) 7 weeks. Delayed type hypersensitivity (DTH) response with leishmanine intradermic reaction (IDR) was higher in CL patients than healthy controls (P<0.05) and increased in active secondary versus primary infection (P<0.001) with diagnostic value 1.74 for active infection and 1.81 postclinical remission. Antibodies to amastigotes characterized by Enzyme Linked Immunosorbent Assay (ELISA) decreased in sera postclinical remission versus active infections (P<0.001), with a diagnostic value from 1.50 to 1.84. Immunoblottings antigenic bands frequency as well as Integral Optical Density (IOD) Area Densitometry decreased with sera from SR, after Glu or VT treatments in CL volunteers. Intracellular parasitism is due to normal antibodies recognizing parasite antigens after inoculation by vector. VT vaccine induced mainly cellular immunity, for remission of lesions and protection from CL infection.
format Article
id doaj-art-2013f53690c24146a4eec2500b77bb5f
institution Kabale University
issn 2090-0023
2090-0031
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Parasitology Research
spelling doaj-art-2013f53690c24146a4eec2500b77bb5f2025-02-03T06:11:36ZengWileyJournal of Parasitology Research2090-00232090-00312013-01-01201310.1155/2013/657016657016Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different TreatmentsJosé A. O'Daly0Humberto M. Spinetti1Joe Gleason2María B. Rodríguez3Astralis LTD, 1076 Stuyvesant Avenue, Irvington, NJ 07111, USAInstituto Venezolano de Investigaciones Científicas (IVIC), Altos de Pipe, Km 10 Carretera Panamericana, Caracas 1010A, VenezuelaAstralis LTD, 1076 Stuyvesant Avenue, Irvington, NJ 07111, USAInstituto Venezolano de Investigaciones Científicas (IVIC), Altos de Pipe, Km 10 Carretera Panamericana, Caracas 1010A, VenezuelaAmastigotes from L. (L.)amazonensis (La), L. (L.)venezuelensis (Lv), L. (V.)brasiliensis (Lb), and L. (L.)chagasi (Lch) were cultured in a free cells liquid culture medium. Patients (n=87) from a cutaneous leishmaniasis (CL) hyperendemic region receiving different treatments were followed up from January 1994 to August 2000. Time for remission of lesions were spontaneous remission (SR) 7 weeks; Glucantime (Glu) chemotherapy 9 weeks; immunotherapy with La, Lv, Lb, and Lch amastigotes Tosyl-Lysil Chloromethyl-ketone (TLCK) treated and Nonidet P-40(NP-40) extracted (VT) 7 weeks. Delayed type hypersensitivity (DTH) response with leishmanine intradermic reaction (IDR) was higher in CL patients than healthy controls (P<0.05) and increased in active secondary versus primary infection (P<0.001) with diagnostic value 1.74 for active infection and 1.81 postclinical remission. Antibodies to amastigotes characterized by Enzyme Linked Immunosorbent Assay (ELISA) decreased in sera postclinical remission versus active infections (P<0.001), with a diagnostic value from 1.50 to 1.84. Immunoblottings antigenic bands frequency as well as Integral Optical Density (IOD) Area Densitometry decreased with sera from SR, after Glu or VT treatments in CL volunteers. Intracellular parasitism is due to normal antibodies recognizing parasite antigens after inoculation by vector. VT vaccine induced mainly cellular immunity, for remission of lesions and protection from CL infection.http://dx.doi.org/10.1155/2013/657016
spellingShingle José A. O'Daly
Humberto M. Spinetti
Joe Gleason
María B. Rodríguez
Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments
Journal of Parasitology Research
title Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments
title_full Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments
title_fullStr Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments
title_full_unstemmed Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments
title_short Clinical and Immunological Analysis of Cutaneous Leishmaniasis before and after Different Treatments
title_sort clinical and immunological analysis of cutaneous leishmaniasis before and after different treatments
url http://dx.doi.org/10.1155/2013/657016
work_keys_str_mv AT joseaodaly clinicalandimmunologicalanalysisofcutaneousleishmaniasisbeforeandafterdifferenttreatments
AT humbertomspinetti clinicalandimmunologicalanalysisofcutaneousleishmaniasisbeforeandafterdifferenttreatments
AT joegleason clinicalandimmunologicalanalysisofcutaneousleishmaniasisbeforeandafterdifferenttreatments
AT mariabrodriguez clinicalandimmunologicalanalysisofcutaneousleishmaniasisbeforeandafterdifferenttreatments